Ribrag, Vincent <br/><br/>
Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial.  [electronic resource] 

 -  Lancet (London, England)  Jun 2016 
 - 2402-11 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1474-547X 
<br/><br/><label>Standard No.: </label>10.1016/S0140-6736(15)01317-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Biomarkers, Tumor--analysis<br/>Bone Marrow Neoplasms--drug therapy<br/>Burkitt Lymphoma--chemistry<br/>Central Nervous System Neoplasms--drug therapy<br/>Cyclophosphamide--administration & dosage<br/>Cytarabine--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Drug Administration Schedule<br/>Female<br/>France<br/>Humans<br/>Hydrocortisone--administration & dosage<br/>Injections, Intravenous<br/>Male<br/>Methotrexate--administration & dosage<br/>Methylprednisolone--administration & dosage<br/>Middle Aged<br/>Neoplasm Staging<br/>Odds Ratio<br/>Patient Selection<br/>Prednisone--administration & dosage<br/>Proportional Hazards Models<br/>Rituximab--administration & dosage<br/>Treatment Outcome<br/>Vincristine--administration & dosage